openPR Logo
Press release

Dry Age-Related Macular Degeneration Patient Pool Analysis Market Projected to Grow at 6.9% CAGR

09-23-2025 01:07 PM CET | Health & Medicine

Press release from: Exactitude Consultancy

Dry Age-Related Macular Degeneration Patient Pool Analysis Market

Dry Age-Related Macular Degeneration Patient Pool Analysis Market

Introduction
Dry age-related macular degeneration (Dry AMD) is a chronic, progressive eye disorder that damages the macula-the central portion of the retina responsible for sharp, straight-ahead vision. Unlike wet AMD, which involves abnormal blood vessel growth, dry AMD is characterized by the accumulation of drusen (yellow deposits) beneath the retina and gradual thinning of macular tissues. While it progresses more slowly, Dry AMD accounts for nearly 85-90% of all AMD cases globally, making it the dominant form of the disease.

The growing prevalence of Dry AMD is directly tied to aging populations and lifestyle risk factors such as smoking, hypertension, and poor diet. With no definitive cure, patient management relies heavily on early diagnosis, lifestyle interventions, supportive therapies, and ongoing monitoring. As the patient pool expands worldwide, the Dry AMD patient pool analysis market is gaining momentum, driven by increasing awareness, innovation in retinal imaging, and investment in drug development pipelines.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72296

Market Overview
• Market Size (2024): USD 9.8 billion
• Forecast (2034): USD 19.2 billion
• CAGR (2024-2034): ~6.9%

Key Highlights:
• Dry AMD affects hundreds of millions of people worldwide, with prevalence rising sharply after the age of 60.
• Expanding diagnostic infrastructure, especially optical coherence tomography (OCT), enhances early detection.
• Growing clinical research into complement inhibitors, antioxidants, and regenerative therapies.
• Lifestyle and nutrition-based interventions (AREDS formulations) remain widely recommended for early-stage patients.

Leading Players: Novartis, Apellis Pharmaceuticals, Genentech/Roche, Bayer, Regeneron, Iveric Bio (Astellas), Bausch + Lomb, and several AI-driven ophthalmic imaging startups.
Key Drivers: Expanding patient pool, rising elderly populations, and advances in imaging and therapy development.
Key Challenges: Lack of curative treatment, high costs of advanced therapies, and underdiagnosis in emerging regions.

Segmentation Analysis
By Product
• Nutritional Supplements (AREDS formulations, antioxidants, vitamins)
• Complement Pathway Inhibitors (emerging drug class)
• Diagnostic Imaging Devices (OCT, fundus photography, autofluorescence imaging)
• Regenerative Medicine & Stem Cell Therapy (in research phase)
• Supportive Devices & Monitoring Tools

By Platform
• Prescription & Over-the-Counter Supplements
• Specialty Biologics & Clinical Trial Drugs
• Diagnostic & Imaging Platforms
• Research & Academic Tools

By Technology
• Optical Coherence Tomography (OCT)
• Fundus Autofluorescence (FAF) Imaging
• AI-Powered Retinal Imaging & Screening
• Gene Therapy & Stem Cell Platforms (under trial)
• Digital Health Monitoring Solutions

By End Use
• Hospitals
• Ophthalmology Clinics
• Ambulatory Care Centers
• Academic & Research Institutes

By Application
• Early-Stage Dry AMD (drusen accumulation)
• Intermediate Dry AMD (geographic atrophy risk)
• Advanced Dry AMD (vision impairment, geographic atrophy)
• Clinical Research & Experimental Trials

Summary: The Dry AMD market remains heavily weighted toward diagnostics and supportive therapies, while new complement inhibitors and regenerative solutions under clinical development are expected to expand treatment options by 2034.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/72296/dry-amd-patient-pool-analysis-market

Regional Analysis
North America
• Largest share due to advanced healthcare infrastructure and high AMD awareness.
• U.S. leading in clinical trial activity for Dry AMD drug development.
• Widespread adoption of OCT and AI-powered retinal imaging.
Europe
• Germany, UK, and France at the forefront of research into complement inhibitors.
• Expanding elderly population driving significant patient pool growth.
• EU rare disease and ophthalmology funding encouraging innovation.
Asia-Pacific
• Fastest-growing region, led by Japan, China, and India.
• Rising prevalence due to demographic shifts and lifestyle risk factors.
• Expanding adoption of advanced imaging devices in urban centers.
Middle East & Africa
• GCC countries investing in retinal diagnostic infrastructure.
• Limited AMD screening programs in Africa, though urban awareness is increasing.
• Growth in medical tourism supporting specialized ophthalmic care.
Latin America
• Brazil and Mexico leading in adoption of nutritional supplements and OCT devices.
• Expanding middle-class population contributing to increased diagnosis rates.
• Ongoing research collaborations with global pharma companies.

Summary: North America and Europe dominate due to innovation and clinical research, while Asia-Pacific is the fastest-growing region, driven by demographics, awareness, and access to advanced diagnostics.

Market Dynamics
Growth Drivers
1. Expanding Elderly Populations: Higher AMD prevalence linked to aging demographics.
2. Diagnostic Advancements: OCT and AI-enhanced retinal imaging enabling early detection.
3. R&D Investment: Strong clinical trial activity for complement inhibitors and regenerative therapies.
4. Lifestyle & Preventive Approaches: Widespread use of supplements improving awareness and management.

Challenges
1. Lack of Curative Therapy: Current options only slow progression, not reverse disease.
2. Underdiagnosis: Millions remain undiagnosed, especially in developing countries.
3. Cost Barriers: Advanced therapies and diagnostics remain expensive.
4. Long-Term Trial Requirements: Clinical validation of new therapies is time-consuming.

Latest Trends
• Complement Pathway Inhibitors: Emerging as a leading drug development target.
• AI Imaging Tools: Supporting early screening and monitoring in primary care.
• Stem Cell Therapy Trials: Showing promise in regenerating retinal pigment epithelium.
• Digital Health Integration: Remote monitoring platforms aiding patient management.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72296

Competitor Analysis
Major Players:
• Novartis AG
• Apellis Pharmaceuticals
• Genentech (Roche)
• Bayer AG
• Regeneron Pharmaceuticals
• Iveric Bio (Astellas Pharma)
• Bausch + Lomb
• Opthea Limited
• AI-driven ophthalmic imaging startups (e.g., RetinAI, DeepMind collaborations)

Competitive Dynamics:
The Dry AMD market is currently diagnostics- and supplement-driven, but competition is intensifying with the development of complement inhibitors, gene therapies, and regenerative solutions. Established pharma companies dominate late-stage trials, while startups and research institutes are pushing innovation in AI diagnostics and novel treatment pathways.

Conclusion
The Dry AMD patient pool analysis market is projected to grow from USD 9.8 billion in 2024 to USD 19.2 billion by 2034, at a CAGR of ~6.9%. Growth is being fueled by rising patient prevalence, expanding diagnostic infrastructure, and strong investment in drug development pipelines.
While the lack of curative therapies and high costs remain challenges, the outlook is optimistic. The next decade will see complement inhibitors, AI-based diagnostics, and regenerative medicine reshape the Dry AMD landscape, expanding treatment opportunities and improving patient outcomes.

This report is also available in the following languages : Japanese (ドライAMD患者プール分析、市場), Korean (건성 AMD 환자 풀 분석, 시장), Chinese (干性AMD患者群体分析、市场), French (Analyse du bassin de patients atteints de DMLA sèche et du marché), German (Analyse des Patientenpools für trockene AMD, Markt), and Italian (Analisi del bacino di pazienti affetti da AMD secca, mercato), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72296

Our More Reports:

Spasticity Market
https://exactitudeconsultancy.com/reports/72074/spasticity-market

Secondary Progressive Multiple Sclerosis Market
https://exactitudeconsultancy.com/reports/72072/secondary-progressive-multiple-sclerosis-market

Primary Progressive Aphasia Market
https://exactitudeconsultancy.com/reports/72070/primary-progressive-aphasia-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dry Age-Related Macular Degeneration Patient Pool Analysis Market Projected to Grow at 6.9% CAGR here

News-ID: 4194031 • Views:

More Releases from Exactitude Consultancy

Tropical Spastic Paraparesis Market: Rising Awareness and Advanced Therapies Drive Growth Through 2034
Tropical Spastic Paraparesis Market: Rising Awareness and Advanced Therapies Dri …
Subheadline: Increasing diagnosis rates, better access to neurology care, and novel antiviral and immunomodulatory therapies are reshaping the global tropical spastic paraparesis (TSP) market landscape. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72081 Introduction The Tropical Spastic Paraparesis (TSP) Market is experiencing gradual yet steady growth, driven by heightened awareness, advanced diagnostics, and improved disease management strategies. Estimated to register a compound annual growth rate (CAGR) of around 5.1% from 2024 to
Cell and Gene Therapy Manufacturing Market: Automation, AI Integration, and Global Partnerships Accelerate Industry Expansion Through 2034
Cell and Gene Therapy Manufacturing Market: Automation, AI Integration, and Glob …
Subheadline: Rising investment in regenerative medicine, advanced manufacturing platforms, and automated bioprocessing systems are transforming the global cell and gene therapy manufacturing landscape. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72379 Introduction The Cell and Gene Therapy Manufacturing Market is at the forefront of the biotechnology revolution, driven by unprecedented demand for personalized medicine, automation in bioprocessing, and expanding clinical pipelines. Valued at USD 14.3 billion in 2024, the market is projected to
Metachromatic Leukodystrophy Market Poised for Transformative Growth Driven by Gene Therapy Breakthroughs and Global Rare-Disease Funding Initiatives - Forecast to 2034
Metachromatic Leukodystrophy Market Poised for Transformative Growth Driven by G …
Sub-headline: Supported by accelerating gene-therapy approvals, newborn screening expansion, and multinational funding collaborations, the global Metachromatic Leukodystrophy (MLD) Market is projected to reach USD 210 million by 2034, expanding at a CAGR of 18.5% from 2025 to 2034. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72057 Introduction Pune, India | November 2025 - According to Exactitude Consultancy, the global Metachromatic Leukodystrophy Market is entering a new era of therapeutic innovation. Once
Biotherapeutics Market to Surpass USD 875.6 Billion by 2034
Biotherapeutics Market to Surpass USD 875.6 Billion by 2034
The market is projected to grow at a CAGR of 8.1% from 2024 to 2034, powered by precision-medicine adoption, biologics innovation, and robust biomanufacturing investment. Pune, India - November 2025 - Exactitude Consultancy announces that the Global Biotherapeutics Market is entering a decade of unprecedented growth as biologic drugs, monoclonal antibodies, vaccines, and advanced cell- and gene-based therapies reshape modern medicine. Rapid progress in protein-engineering, AI-guided drug design, and large-scale biologics

All 5 Releases


More Releases for AMD

Onlive Server Brings AI-Powered AMD Dedicated Servers
We are all aware of how useful, and sometimes even crucial, proper hosting services can be for a business. That is why Onlive Server is providing this new option with the newly recommended AI-powered AMD Dedicated Server Hosting[https://onliveserver.com/amd-dedicated-server-hosting/]. Furthermore, these servers are powered by AMD technology and do superbly in servicing the tremendous demand of agile business workloads with modern AI computations, big data, and other emerging technologies. AI-powered solutions are
06-13-2024 | Health & Medicine
Fact.MR
Age-Related Macular Degeneration Market To Expand, Fuelled By Innovations In Dry …
The Age-related Macular Degeneration Market (AMD) is poised for significant growth over the coming years, with projections indicating a compound annual growth rate (CAGR) of 6.2%, leading to an estimated market value of $20 billion by the end of the forecast period. This robust expansion is driven by several critical factors, including the rising prevalence of eye diseases, advancements in medical technology, and an aging population that is increasingly susceptible
AMD Workstations Market | BIZON, BOXX Technologies, Broadberry, Dell
The global amd workstations market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the amd workstations market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the
Airway Management Products (AMD) Market 2021 | Detailed Report
Airway Management Products (AMD) Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5262437 The report provides a comprehensive analysis of company profiles listed below: - Medtronic - Teleflex - Ambu - Smiths Medical - Intersurgical - Becton Dickinson - Armstrong Medical - Medline Industries Airway Management Products
Age-Related Macular Degeneration (AMD) Market Report 2018: Segmentation by Type …
Global Age-Related Macular Degeneration (AMD) market research report provides company profile for F. Hoffmann-La Roche AG, Regeneron Pharmaceutical Inc., Novartis AG, Bayer AG, Santen Pharmaceuticals and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.
Global Microprocessor Market 2018 - Intel, Qualcomm, Apple, AMD
Apex Market Reports, recently published a detailed market research study focused on the “Microprocessor Market” across the global, regional and country level. The report provides 360° analysis of “Microprocessor Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Microprocessor on the basis of